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Abstract 
Background: The diagnosis of peribronchial pulmonary lesions located in the tertiary bronchi, also 
known as segmental bronchi, as well as, the 4th order and 5th order segmental bronchi is very difficult. 
Histopathological specimens cannot be easily obtained by endobronchial biopsies (EBBX) due to the 
patent but small segmental bronchial lumen. The aim of the present study was to evaluate the diagnostic 
accuracy and safety of the novel technique with radial probe endobronchial ultrasound (R-EBUS) assisted 
conventional transbronchial needle aspiration (C-TBNA) in the diagnosis of solitary peribronchial 
pulmonary lesions located in segmental bronchi from 3th to 5th order.  
Methods: From December 2014 to December 2015, 16 patients with solitary peribronchial pulmonary 
lesions in the segmental bronchi from 3th to 5th order confirmed by computed tomography (CT) were 
enrolled. The lesions were located using radial probe endobronchial ultrasound (R-EBUS) to determine 
the sites of conventional transbronchial needle aspiration (C-TBNA), then, histopathological specimens 
were obtained using the technique of C-TBNA. The final pathological diagnosis was made based on the 
findings from the surgical specimens. Statistical analyses were performed for specimen results and 
complications.  
Results: On pathological evaluation, 14 of the 16 specimens were malignant, including 8 
adenocarcinomas, 4 squamous cell carcinomas, and 2 small cell carcinomas, while 2 were non-malignant 
diseases. The diagnostic accuracy rate, sensitivity and missed diagnosis rates were 87.5%, 87.5% and 
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12.5%, respectively. When Combined the results of cytology with histologic samples obtained from 
C-TBNA the total diagnostic accuracy rate, sensitivity and missed diagnosis rate were 93.75%, 93.75% 
and 6.25%, respectively. There were 2 cases of bleeding complications >5 mL after C-TBNA, and both 
were resolved with endobronchial management.  
Conclusions: The combination of R-EBUS with C-TBNA was advantageous and safe for the diagnosis of 
solitary peribronchial pulmonary lesions located in the segmental bronchi. However, possible bleeding 
complications should be anticipated with needle aspiration. Further verification of this combined 
application should be investigated in larger clinical trials. 
Key words: radial probe endobronchial ultrasound, conventional transbronchial needle aspiration, segmental 
bronchi, pulmonary lesions, bronchoscope, diagnosis 
Introduction 
At present the global incidence of lung cancer is 
increasing with each passing year. Early diagnosis of 
lung cancer is critical for patients [1]. Clinically, there 
are instances of undiagnosed small solitary 
peribronchial pulmonary lesions located in segmental 
bronchi from 3th to 5th order with the lumen of 2–4 
mm in diameter, because the diagnostic procedures 
for tissue biopsy are very difficult [2, 3]. Tissue cannot 
be easily reached by endobronchial biopsies (EBBX) 
due to the diameter of the patent bronchial lumen, 
while the other test of conventional diagnostic 
bronchoscopic procedures such as lavaging and 
brushing tend to obtain low positive cytological 
results. Furthermore, the endobronchial ultrasound 
guided transbronchial aspiration (EBUS-TBNA) 
cannot reach the lesions due to the large size of 
current convex probe of the EBUS bronchoscope with 
a 6.9 mm diameter. CT-guided percutaneous biopsies 
are associated with a higher risk of complications 
including pneumothorax or hemoptysis given the 
small lesions’ locations often near large blood vessels 
and the heart [4, 5]. Therefore, we performed this 
study to develop a more effective diagnostic method 
for solitary peribronchial pulmonary lesions located 
in segmental bronchi. In this study, 16 patients with 
solitary peribronchial pulmonary lesions located in 
the segmental bronchi from 3th to 5th order 
underwent R-EBUS assisted C-TBNA for pathological 
diagnosis [3]. The lesions were first located using 
R-EBUS to determine the target sites for puncture and 
then C-TBNA was performed to obtain cytologic and 
histologic specimens. A final pathological diagnosis 
was made based on the findings from the subsequent 
surgical specimens obtained by thoracic surgery. 
Finally, statistical analyses were performed for 
specimen results and complications. This study was 
conducted to evaluate the diagnostic accuracy and 
safety of the novel R-EBUS assisted C-TBNA 
technique in the diagnosis of solitary peribronchial 
pulmonary lesions located in the segmental bronchi. 
 
1. Patients and Methods 
1.1 Patients  
A retrospective analysis of bronchoscopic 
procedures was performed in the bronchoscopy suite 
of Changhai hospital between December 2014 and 
December 2015. During this period, 5085 
bronchoscopic procedures were performed, among 
which 3376 were diagnostic. Out of the 3376 
diagnostic bronchoscopies, R-EBUS was used to 
identify 188 lesions. Thirty of these 188 lesions were 
located in the segmental bronchi from the 3rd to 5th 
order. Based on the bronchoscopic findings, 16 out of 
these 30 lesions were in peribronchial with a patent 
endobronchial lumen. The distribution of these 16 
lesions is shown in Figure 1. Therefore, in the present 
study these 16 patients (13 male and 3 female; mean 
age, 59.63 ± 11.10 years; age range, 33–77 years) 
underwent R-EBUS assisted C-TBNA for pathological 
diagnosis.  
Inclusion criteria: Solitary peribronchial 
pulmonary lesions located in the segmental bronchi 
from 3th to 5th order were confirmed by CT. No 
mediastinal or hilar lymph node enlargement was 
found. Endobronchial lumens were patent by the 
detection of bronchoscopic findings as well as 
R-EBUS. Exclusion criteria: 1) severe 
cardiopulmonary dysfunction 2) coagulopathy 3) 
patients unable to tolerate bronchoscopic procedures. 
All the patients had signed informed consents, and 
this study was approved by the ethics committee of 
Changhai Hospital.  
1.2 Methods 
1.2.1 Preoperative Preparation: 
The patients were fasted for 8 hours and 
prohibited from drinking water for 4 hours before the 
examination. Pulmonary spiral CT scan, blood tests, 
and ECG were performed as routine examinations. 
Two bronchoscopists, who were proficient in 
C-TBNA and endobronchial ultrasound techniques, 
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reviewed the chest CT before procedure to make sure 
the location of the solitary lesions.  
1.2.2 Operation: 
As shown in Figure 2, the puncture process was 
divided into three steps: location, measurement and 
puncture. 
The first step was to find the segmental bronchi 
with peribronchial lesion by R-EBUS, namely location. 
When operating, the bronchoscopist inserted the 
bronchoscope into the segmental bronchi closest to 
the lesion according to the CT scan. Then the R-EBUS 
probe was inserted into the segmental bronchi by the 
working channel of bronchoscope, the R-EBUS probe 
was operated and scanned with a 360-degree ring to 
obtain the complete ultrasonic image of peribronchial 
lesion, and all the bronchi in the target area were 
searched in turn. When the R-EBUS probe got the best 
ultrasounic image of the peribronchial lesion, the 
segmental bronchi with peribronchial lesion were 
recorded remembered. 
 
 
Figure 1. The distribution of all the solitary peribronchial pulmonary 
lesions. As shown above the distribution of all the 16 solitary peribronchial 
pulmonary lesions is: 3 lesions were present in the RUL, 1 lesion was in the RML, 1 
lesion was in the RLL(S), 3 lesions were in the RLL(B), 1 lesion was in the LUL, 1 lesion 
was in the LUL(L), 1 lesion was in the LLL(S), and 5 lesions were in the LLL(B). The 
numbers in the figure followed the sequence of patients’ enrollment. (RUL=right 
upper lobe, RML=right middle lobe, RLL(S) =superior segment of right low lobe, 
RLL(B)=basal segment of right low lobe, LUL=left upper lobe, LUL(L)=lingular 
segment of left upper lobe, LLL(S)=superior segment of left low lobe, LLL(B)=basal 
segment of left low lobe.) 
 
 
 
Figure 2. The puncture process with R-EBUS assisted C-TBNA for solitary peribronchial lesion in the segmental bronchi. The puncture process was divided 
into 3 steps with location, measurement and puncture in sequence, the breakdown of each step was detailed as shown.  
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Then, the distal end of bronchoscope was 
wedged in the nearest segmental bronchus of 
peribronchial lesion. The assistant was instructed to 
seize the body of bronchoscope at the level of nose or 
mouth to ensure bronchoscope not moving. The 
second step was to measure the size of lesion by 
R-EBUS, namely measurement. Because the diameter 
of the bronchial lumen was larger than the R-EBUS 
probe at the detection site, we used the R-EBUS probe 
to scan the bronchial wall clockwise until finding the 
peribronchial lesion. When the ultrasonic probe found 
the peribronchial lesion, the position and the angle of 
the ultrasonic probe is the exact endobronchial 
puncture position and the best puncture angle of the 
peribronchial lesion (action a). Then, the length 
(action b) and maximum diameter (action c) of the 
peribronchial lesion were measured by identifying the 
proximal, distal, and transverse margins utilizing the 
ultrasonic image. The R-EBUS probe was then 
withdrawn to measure the length between the 
proximal end of the lesion and the distal end of the 
bronchoscope (action d). The R-EBUS probe was 
subsequently withdrawn and the 19G WANG TBNA 
needle was inserted through the working channel of 
the bronchoscope. The TBNA guide-needle was 
extended from the distal end of the bronchoscope as 
determined by action d. The direction as well as the 
angle of the C-TBNA needle entering the lumen of the 
segmental bronchi should refer to action a. When the 
bronchoscopist confirmed that the C-TBNA needle 
had reached the optimal puncture position and angle, 
the assistant deployed the 19G WANG TBNA needle 
core, and the bronchoscopist performed needle 
aspiration biopsy of the peribronchial lesion by 
C-TBNA. Since the X-ray fluoroscopy was not used, 
the “jobbing technique” or “hub against the wall 
technique” was necessary to be used for 
bronchoscopist to avoid the failure of C-TBNA caused 
by the position movement of bronchoscope [6]. The 
angle of needle biopsy was according to action b and 
c. During the needle puncture and aspiration, where 
visual imaging with the bronchoscope was still 
available in the lumen of segmental bronchial. If the 
needle could not be penetrated through the bronchial 
wall, the needlepoint was probablely blocked by the 
crest of segmental bronchial. The bronchoscopist then 
readjusted the endobronchial position of C-TBNA 
needle to puncture again. If necessary, the TBNA 
needle was withdrawn and the ultrasonic probe 
reentered to scan the peribronchial lesion and 
determine the optimal endobronchial puncture site 
with angle, and then the C-TBNA was redone again. 
When the puncture needle successfully penetrated 
through the wall, the assistant then locked the 
puncture needle, it was connected to a 60 mL syringe 
for suction, and the bronchoscopist repeated a rapid 
jitter or pushed the needle back and forth for several 
times.  
1.2.3 Specimen Processing: 
The bronchoscopist withdrew the needle with 
suction off, removed the whole needle assembly from 
the working channel of the scope and released the 
specimens from the tip of needle for liquid-based 
cytology, and histological specimens were removed 
and fixed in 10% formalin for histopathology. Some 
patients underwent endobronchial lavaging and 
brushing after the puncture, and the specimens were 
arranged for cytology and the detection of 
acid-resistant bacilli. Every peribronchial lesion 
underwent needle puncture 2-3 times. 
1.2.4 Anaesthesia Method: 
All patients were evaluated by an 
anesthesiologist, and different anesthesia methods 
including local anesthesia and sedation were selected 
according to the patients' status and wishes. We 
initially recommended moderate sedation, which was 
intravenous anesthesia combined with local 
anesthesia. Patients received oral nebulization of 10 
mL 2% lidocaine injection for oropharyngeal 
anesthesia, as well as lidocaine gel for nasal 
anesthesia. Then, the open superficial venous 
micropump was used to pump an inductive dose of 
dexmedetomidine at the speed of 1 μg/kg. The pump 
was set up to be emptied in 10-15 min. Then, a 
maintenance dose was administered at the speed of 
0.5-0.7 μg·kg-1·h-1. After the patient fell asleep, a 
maintainance dose of midazolam 0.03-0.05 mg/kg 
and fentanyl 25-50 μg were slowly administered 
during the procedure. If necessary, the 
nasopharyngeal airway tube was put to clear the 
upper respiratory tract. For patients with high risk for 
sedation such as uncontrolled hypertension and 
arrhythmia, only local anesthesia by means of 
oropharyngeal nebulization and nasal anesthesia 
were used. 
1.2.5 Apparatus: 
All procedures were performed using an 
electronic flexible bronchoscope (Olympus 1T260 or 
Olympus 1TQ290, Olympus Medical Systems Co. Ltd, 
Tokyo, Japan), ultrasonic host (EV-ME1 universal 
ultrasonic endoscope image processing device, 
Olympus Medical Systems Co. Ltd., Tokyo, Japan), 
R-EBUS with a 1.7 mm diameter (UM-S20-20R, 
Olympus Medical Systems Co. Ltd., Tokyo, Japan), 
WANG™ transbronchial aspiration histology needles 
(MWF-319, ConMed Company, New York, USA), and 
a cell brush (Nanjing Micro-tech Medical Science and 
Technology Co., Ltd., Nanjing, China). 
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Table 1. Demographics of patients with solitary peribronchial pulmonary lesions  
Case no. Age/ 
Sex 
Peribronchial 
Lesion location 
Lesion diameter 
(mm) 
C-TBNA pathology C-TBNA 
cytopathology 
Airway 
washing 
Airway Brushing Surgical pathology 
1 55/M LUL.B5 11×8×9 adenocarcinoma malignant cell, 
suspicious NSCLC 
negative negative primary 
adenocarcinoma 
2 47/M RLL.B8 17.9×15.8×16 suspicious 
adenocarcinoma 
malignant cell, 
suspicious NSCLC 
negative malignant cell, 
suspicious NSCLC 
primary 
adenocarcinoma 
3 45/M RUL.B3 29.4×27×34.5 suspicious small cell 
carcinoma 
malignant cell, 
suspicious SCLC 
— — small cell carcinoma 
4 61/F LLL.B9 13.2×15×16.9 suspicious 
adenocarcinoma 
malignant cell, 
suspicious NSCLC 
negative — adenocarcinoma 
5 63/M RUL.B3 14.7×13.2×16.5 small cell carcinoma malignant cell, 
suspicious SCLC 
negative negative small cell carcinoma 
6 63/M LLL.B9 b 10×15.1×13 adenocarcinoma malignant cell, 
suspicious NSCLC 
negative negative primary 
adenocarcinoma 
7 77/M RLL.B6 25.3×23×19 suspicious squamous 
cell carcinoma 
squamous cell 
carcinoma 
negative negative squamous cell 
carcinoma 
8 60/M RLL.B7 15.6×12×13 suspicious 
adenocarcinoma 
malignant cell, 
suspicious NSCLC 
negative adenocarcinoma cell primary 
adenocarcinoma 
9 62/M RUL.B2a 17.5×16.9×15 squamous cell 
carcinoma 
squamous carcinoma 
cell 
negative negative primary squamous cell 
carcinoma 
10 63/M LLL.B9 14×12×15.5 suspicious 
adenocarcinoma 
malignant cell, 
suspicious NSCLC 
negative negative primary 
adenocarcinoma 
11 75/M LLL.B6c 30×26×35 suspicious squamous 
cell carcinoma 
negative  negative squamous carcinoma 
cell 
primary squamous cell 
carcinoma 
12 54/M LLL.B10 21.3×17×15 adenocarcinoma malignant cell, 
suspicious NSCLC 
— adenocarcinoma cell primary 
adenocarcinoma 
13 70/M RML.B4 7×12.8×9 suspicious 
adenocarcinoma 
malignant cell, 
suspicious NSCLC 
— — primary 
adenocarcinoma 
14 33/F RLL.B9+10 21.4×17×19 suspicious squamous 
carcinoma cell 
squamous carcinoma 
cell 
— — primary squamous cell 
carcinoma 
15 62/F LLL.B9 16.5×15×21.1 non-malignant disease malignant cell, 
suspicious NSCLC 
— — primary 
adenocarcinoma 
16 64/M LUL.B1 11×8×9 non-malignant disease negative — — no clinical follow-up 
M=male, F=female, RUL=right upper lobe, RML=right middle lobe, RLL=right low lobe, LUL=left upper lobe, B=bronchus, NSCLC=non-small cell lung cancer, SCLC=small 
cell lung cancer, LLL=left low lobe, C-TBNA=conventional transbronchial needle aspiration.  
 
 
1.3 Statistical analysis 
SPSS version 16.0 (IBM SPSS Statistics, IBM 
Corporation, Armonk, New York, USA) was adopted 
to perform the statistical analyses. Quantitative values 
were expressed asx±SD and the statistical 
significance was determined by t-test. Numerical 
values were presented as percentages (%). P < 0.05 
was considered statistically significant. 
2. Results 
2.1 Distribution and size of pulmonary lesions 
The patients’ demographic characteristics 
including the pulmonary lesion locations and sizes 
were shown in Table 1. The mean diameter of these 
lesions was 19.28 ± 7.16 mm.  
2.2 The anesthesia for patients 
In brief, sedation was performed to 11 patients 
with a mean age of 56.73 ± 9.40. Local anesthesia was 
performed to 5 patients with a mean age of 66.00 ± 
12.92. R-EBUS assisted C-TBNA was successfully 
performed under both anesthesia methods. We 
analyzed the age of patients with different anesthesia 
methods and found that there was no statistically 
significant difference between two groups (P = 0.12). 
2.3 Histopathologic and cytologic results of 
C-TBNA 
C-TBNA was performed for all the 16 patients, 
and the pathological results were shown in Table 1. 
C-TBNA histopathological evaluation of the 16 tissue 
specimens showed that 14 cases were malignant, 
including 8 adenocarcinomas, 4 squamous cell 
carcinomas, and 2 small cell carcinomas, and the 
remaining 2 were non-malignant disease. With 
respect to cytologic results of C-TBNA, 14 were 
malignant, and the remaining 2 were non-malignant. 
Combining both results, 15 were malignant, including 
9 adenocarcinomas (56.25%), 4 squamous cell 
carcinomas (25.00%), and 2 small cell carcinomas 
(12.50%), 1 was non-malignant (6.25%) and the patient 
had no clinical follow-up. 
2.4 Accuracy of different procedures 
According to the patients’ states after C-TBNA, 
some of patients underwent endobronchial 
bronchoscopic washing and brushing for cytological 
test; lavaging was performed for 10 patients with all 
negative results. Brushing was performed for 10 
patients, malignant cell were found only in 4 out of 10. 
However, C-TBNA was performed for all 16 patients, 
and 15 of these were malignant. Comparing to the 
result of final surgical pathology, the diagnostic 
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accuracy rate, sensitivity and missed diagnosis rate of 
the cytological results of washing were 0, 0 and 100%, 
respectively. The diagnostic accuracy rate, sensitivity 
and missed diagnosis rate of the cytological the 
results of brushing were 40%, 40% and 60%. However, 
the accuracy rate, sensitivity and missed diagnosis 
rate of histopathological results of C-TBNA, were 
87.5%, 87.5% and 12.5%, respectively. The diagnostic 
accuracy rate, sensitivity and missed diagnosis rate of 
C-TBNA cytological results were 87.5%, 87.5% and 
12.5%, respectively. Upon combining both results 
above, the total diagnostic accuracy rate, sensitivity 
and missed diagnosis rate were 93.75%, 93.75% and 
6.25%, respectively (Table 2). 
 
Table 2. Analysis of the results of different diagnostic procedures 
Procedure Accuracy rate 
(%) 
Sensitivity  
(%) 
missed diagnosis 
rate 
(%) 
Histopathological results 
 of C-TBNA (n = 16) 
87.5% 87.5% 12.5% 
Cytological results of C-TBNA (n 
= 16) 
87.5% 87.5% 12.5% 
Cytological results of brushing (n 
= 10) 
40% 40% 60% 
Cytological results of washing (n 
= 10) 
0 0 100% 
 
2.5 Complications 
There were no occurrences of pneumothorax, 
mediastinal emphysema, or mediastinal hemorrhage 
in any patient. Only 2 patients had complications of 
>5 mL bleeding after needle puncture, but the 
bleeding was controlled quickly with bronchoscopic 
management of bronchoscopic wedge technique and 
endobronchial ice-saline injection. 
3. Typical cases 
A 55-year-old male patient presented with 
symptoms of hemoptysis for 10 days. CT confirmed a 
peribronchial lesion with 11 × 8 × 9 mm in size and 
located in the lingular lobe of Left upper lobe (Figure 
3a). Initial bronchoscopic airway exam was normal 
(Figure 3b), and the lumen of segmental bronchi was 
patent. The endobronchial lavaging and brushing 
were performed and both cytological results were 
negative. Then the second diagnostic bronchoscopic 
procedures with R-EBUS assisted C-TBNA was 
performed 2 days later. R-EBUS was used to reach a 
peribronchial lesion in the orifice B5 segment of LUL. 
The ultrasonic imaging from radial probe showed a 
peribronchial solid nodule with continuous clear 
edge, and 11 mm in the maximum diameter (Figure 
3c). After the needle puncture site with angle was 
confirmed by R-EBUS, the radial probe was pulled 
out, then the TBNA needle with 19G in size was 
inserted through the working channel of the 
bronchoscope. The “jabbing technique” of C-TBNA 
needle puncture was performed according to the 
initial evaluation of R-EBUS (Figure 3d). Satisfactory 
specimens were obtained, and the histopathological 
results of C-TBNA showed adenocarcinoma (Figure 
3e). The non-small cell cancer cells were found in the 
cytological results of C-TBNA (Figure 3f). The patient 
underwent thoracic surgery 5 days later. It was 
confirmed that pathology of the surgical specimen 
was consistent with the result of C-TBNA. The final 
diagnosis of low-differentiated primary 
adenocarcinoma of LUL was confirmed by 
immunohistochemical result subsequently. 
 
 
Figure 3. R-EBUS assisted C-TBNA in the diagnosis of a peribronchial 
pulmonary nodule located in the segmental bronchi of LUL. (a) A solid 
pulmonary nodule located in the lingular lobe of LUL. (b) Initial bronchoscopic airway 
exam was normal, the lumen of the segment B5 of LUL was patent. (c) The ultrasonic 
imaging from radial probe showed a solid peribronchial nodule with continuous clear 
edge, and 11 mm in the maximum diameter. (d) The C-TBNA was performed using 
MW-319 WANG's needle according to the initial evaluation with puncture site and 
angle obtained by R-EBUS probe. (e) The HE staining of C-TBNA specimen showed 
typical adenocarcinoma. (f) Malignant cell, suspicious non-small cell lung cancer was 
found by the cytological result of C-TBNA. 
 
4. Discussion 
In 1949, Transbronchial needle aspiration, 
C-TBNA was first proposed by Dr. Eduardo 
Schieppati in Argentina in diagnosing mediastinal 
lymph nodes of the central airway by the rigid 
bronchoscope [7]. Then, in 1978, Ko-Pen Wang in the 
United States improved the method [8] then C-TBNA 
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could be performed by flexible bronchoscope. Wang 
not only drew the “Wang’s TBNA map”, systemically 
described the puncturing methods of mediastinal and 
hilar lymph nodes [9] and designed a series of 
C-TBNA needles [10, 11], but also focused on the 
development and clinical application of C-TBNA 
puncture techniques. Owing to this, the C-TBNA 
technique had been the standard method of diagnosis 
of mediastinal and hilar lymph nodes in the central 
airway for over 20 years. For an experienced 
bronchoscopist, the diagnostic yield of mediastinal 
and hilar lymph nodes by C-TBNA was between 
96-100% [12], while the diagnostic yield of 
fluoroscopy assisted transbronchial biopsy (TBBX) 
and C-TBNA could fluctuate between 48% and 69% in 
the diagnosis of pulmonary peripheral lesions (PPLs) 
[13-15]. C-TBNA became one of the key technologies 
in diagnostic bronchoscopies. However, with the 
development of bronchial ultrasonic technologies, 
especially after 2004, following clinical promotion of a 
new type of convex probe endotracheal ultrasonic 
bronchoscope (CP-EBUS), EBUS-TBNA was accepted 
by clinicians as a safe and efficient technique for 
mediastinal and hilar lymphadenopathy gradually. 
At present, the sensitivity and specificity of 
EBUS-TBNA could reach 89.89% and 72.73% 
respectively in the pathological diagnosis of 
mediastinal and hilar lymph nodes [16-18]. 
EBUS-TBNA has expanded the role of C-TBNA in the 
staging and diagnosis of lung cancer. With the rise of 
modern navigation technologies, the exploration rate 
of PPLs can also reach 80–90% [2]. C-TBNA, therefore, 
was considered to be an essential technology in both 
the central airway and in pulmonary peripheral 
lesions [19].  
In the present study, all the 16 peribronchial 
lesions were located in the segmental bronchi from 
3rd to 5th order, where the patent lumen of segmental 
bronchi was 2-4 mm in diameter. Any technique of 
endobronchial forceps biopsy, including EBUS-GS 
was not able to reach the peribronchial lesions, while 
the EBUS-TBNA scope could not get into the lumen of 
the fourth bronchus due to the large size of convex 
probe either. Therefore, C-TBNA has become the only 
effective diagnostic method to obtain pathological 
tissue samples. However, there is no “map” available 
for the peribronchial lesions located in the segmental 
bronchi, which is different from the fixed distribution 
of the mediastinal and hilar lymph nodes of the 
central airway [9], and the endobronchial puncture 
site of C-TBNA may be very difficult to identify 
according to the chest CT imaging, even for 
experienced bronchoscopists. Therefore, we first used 
R-EBUS to scan the bronchi to find the peribronchial 
lesion depending on the chest CT imaging. After the 
solid peribronchial lesion and the peripheral blood 
vessels were located, the best angle, location, and 
depth of the needle puncture were determined by the 
R-EBUS. Then the C-TBNA procedure using a 19G 
WANG TBNA needle was performed. As the 
diameter of proximal endobronchial lumen was more 
than 4 mm widely, there was enough space to visually 
adjust the angle of C-TBNA needle, so that the needle 
could be advanced to the ideal puncture position with 
subsequent performance of the conventional method 
of C-TBNA [6]. The diagnostic yield could be 
enhanced by the combined techniques with C-TBNA 
assisted R-EBUS according to our study. 
This study also suggested that the current 
R-EBUS needed to be improved in probing the depth 
of the peribronchial pulmonary lesions. Further, there 
was no doppler function equipped with the present 
ultrasonic radial probe, so it was not effective in 
distinguishing the peripheral blood vessels closed to 
the lesion, and this also caused bleeding 
complications during the needle puncture. In 
addition, for a peribronchial lesion located in the 
upper lobe, the C-TBNA procedure using 19G tissue 
needle combined with a therapeutic bronchoscope 
sometimes could not be implemented effectively due 
to limited bending angle of therapeutic bronchoscopic 
insertion part. Therefore, it is necessary to develop 
equipment for increasing the diagnostic yield in the 
future. Fortunately, updated C-TBNA techniques as 
well as new types of puncture needles for different 
puncture sites are now available, which have 
promoted renewal of C-TBNA [20, 21]. In addition, 
new advanced navigation systems, such as virtual 
bronchoscopic navigation (VBN) system could be 
used to evaluate the peribronchial lesions, guide the 
needle puncture site, angle and depth, as well as 
reconstruct the large blood vessels around bronchi, 
and the VBN system offers a more comprehensive and 
three-dimensional identification, especially in the 
adjacent relationship between peripheral blood 
vessels surrounding the lesion as well as the 
important organs. This helps the C-TBNA to be a safe 
and efficient method to further improve the 
diagnostic yield and reduce the complications of 
bleeding [22-24] (Figure 4). 
Similar to our present study, Hanaoka et al. [25] 
used VBN-assisted C-TBNA in the diagnosis of 
smaller peribronchial lesions with average size of 
11.47 ± 3.4 mm. C-TBNA was used for obtaining the 
specimens for all the 15 cases. However, different 
from our research, C-TBNA needle with 21 G in size 
was used for the needle aspiration, and the C-TBNA 
needle was guided to reach the lesion via X-ray 
fluoroscopy, which could be used to perform the 
C-TBNA biopsy for smaller lesions located in more 
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distal airways. The diagnostic yield could reach 70% 
with fewer bleeding complications during the 
puncture. Both investigations showed the value of 
C-TBNA technology in diagnosing peribronchial 
pulmonary lesions located in the segmental bronchi.  
 
 
Figure 4. 3D anatomical schematic diagram of a peribronchial pulmonary 
lesion with surrounding structures reconstructed by the VBN system. (a) 
3D anatomical schematic diagram reconstructed by the VBN system showed a 
peribronchial lesion located in the lingular lobe of left upper lobe, the 
tracheobronchial tree with surrounding large blood vessels. The green mark within 
the yellow circle showed the lesion (Lung Point® AR Bronchoscopic Navigation, 
Broncus Medical, Inc.). (b) The lesion could be easily recognized by the fluoroscopy 
with the help of combination imaging of 3D anatomical schematic diagram and 
coronary chest CT imaging. (c) The endobronchial location of the solitary 
peribronchial lesion was seen with the VBN bronchoscopy. (d) During bronchoscopic 
airway exam, the corresponding position of the peribronchial lesion was marked 
realtimely to assist the C-TBNA procedure to efficiently obtain the pathological 
tissue. The final cytological results showed no malignant findings. After 1 year 
follow-up, the lesion in the left upper lobe shrinked obviously.  
 
Undeniably, there were limitations in the present 
study. Not all the patients underwent contrast chest 
CT scan before the endobronchial procedures, which 
resulted in the occurrence of bleeding complication in 
2 patients. In addition, all procedures were performed 
by two experienced bronchoscopists. The data is 
retrospective and limited. Most cases were malignant, 
and one negative case was not clinically followed up. 
Therefore, future research on prospective, 
large-sample data is required. 
In recent years, more and more studies have 
shown the value of C-TBNA in needle aspiration 
biopsy of the peripheral pulmonary lesions (PPLs) 
farther from the central airway. Sasada et al. [26] 
diagnosed PPLs through EBUS-GS-TBNA. A 21G 
needle was used to obtain specimens through the 
EBUS-GS. The results showed that there was no 
statistical difference in the diagnosis yield of the 
“within” PPLs or “outside” lesions with the guided 
sheath (GS)-TBNA needle aspiration biopsy [27]. By 
comparing the diagnostic yield of GS-TBNA, 
transbronchial catheter aspiration (TBCA) and TBBX 
in the PPLs, Franke et al. [28] found that GS-TBNA 
had a higher diagnostic yield for malignant PPLs, and 
its diagnostic yield was about twice that of TBBX in 
combination with the result of TBCA. A recent 
meta-analysis of 18 clinical studies showed that 
C-TBNA was significantly better than TBBX in the 
diagnosis of PPLs [29]. The results of AQuIRE of the 
multi-center prospective study of Ost et al. pointed 
out that for PPLs, the new navigation technology did 
not achieve the high diagnostic yield, however, 
C-TBNA was a key technique to improve the 
diagnostic yield of PPLs [30-32]. Nevertheless, the 
application of C-TBNA still faces many challenges in 
the diagnosis of peribronchial lesions. For example, it 
is very difficult to adjust the puncture angle of the 
needle due to the limited diameter of the smaller 
peripheral airway lumen. In addition, there are no 
standard methods currently recommended for the 
procedure of PPLs needle aspiration biopsy. 
Furthermore, PPLs with ground glass opacity (GGO) 
in CT imaging may not be easily appreciated by X-ray 
fluoroscopy and operators still face the problem of 
excessive radiation exposure when X-ray are used. 
Fortunately, bronchoscopists’ have been able to 
effectively locate and biopsy the GGO PPLs even with 
less radiographic exposure with the help of new 
navigation techniques such as Conebeam CT [33, 34]. 
Furthermore, new TBNA needle and puncture 
methods for PPLs are also being developed in recent 
years [35]. Regarding fine needle biopsy under CT 
guidance the needle is definitely larger 18G and 
higher, however; the complication of pneumothorax 
is more often. The specimen also is all the time tissue 
compared to needles of ≤ 25G which are often used for 
technical reasons with endoscopic techniques. Several 
times it is up to the setting of each hospital/institution 
expertise and equipment to decide for each patient 
what is the appropriate method of biopsy. 
Taken together, C-TBNA still exists as a core 
diagnostic bronchoscopic technique, which will have 
great application in prospect. With the development 
of new technology, use of transbronchial needle 
aspiration will steadily advance from the central 
airway to the PPLs to improve the diagnostic yield, 
simplify the biopsy method, and improve the overall 
safety of the procedure. Therefore, the fundamental 
C-TBNA training still needs to be strengthened. 
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